• Five Key Things About the SAC Insider Case
  • Merck Insomnia Drug Safe Only in Low Doses
  • Merck Halts Development of Parkinson’s Drug on Lack of Benefit
  • Emerging Stocks Cap Biggest Decline in 10 Months on China
  • J&J Drugs to Create Next Wave of Growth, Duato Says
  • Merck Insomnia Drug Safe Only in Lower Doses, Panel Says
  • AbbVie Price Boost of Drug Slammed in Studies Criticized
  • Alex Denner Joins Vivus Activist Slate in Post-Icahn Move
  • Forest Labs’ 85-Year-Old CEO Solomon to Leave at Year End
  • J&J Sees 10 Products Submitted for Approval by 2017
  • MS Patients Choose Death Risk With Potent Drug Treatment
  • Elan Board Unanimously Rejects $6.4 Billion Takeover Offer
  • Merck's Magic Sleeping Pills Wake Up Big Pharma
  • The Top Ten Stocks for Thursday, May 23
  • Emerging Stocks Head for Biggest Drop in 10 Months
« Previous 1 2 3 4 5 Next »